July 21, 2020, 03.04 PM

The allocation of a vaccine to developing countries is the priority for the Bill and Melinda Gates Foundation.

Read also: Novartis Scraps Fees of Covid-19 Drugs for Developing Countries

"Nothing has been finalized yet. We continue to have those discussions," Wolk told Reuters.

"People from the countries and the organizations we mentioned want to lock in a certain minimum level of capacity that they would get."

Wolk said that the "general construct" of the discussions is likely to take a form similar to AstraZeneca Plc’s deal with the US government.

The US government provided $1.2 billion in drug development aid to the UK drugmaker in exchange for locking in a delivery of around 300 million doses for fall 2020.

AstraZeneca has also signed a contract with France, Germany, Italy, and the Netherlands for up to 400 million doses of its potential vaccine.

Read also: Indonesia Eyes Local Covid-19 Vaccine Mass Production by Mid-2021

It has also partnered with non-profits to ensure distribution to developing countries.

Wolk added that these discussions will help Johnson & Johnson determine pricing for its vaccine, which the US drugmaker intends to sell on a not-for-profit basis during the pandemic.


Latest Video Video Lainnya >

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

November 28, 2022, 05.16 PM

Death Toll from Indonesia Quake Rises to 321

November 24, 2022, 05.14 PM

Malaysia: Opposition Leader Anwar Ibrahim Named PM

Close Ads